GOSS
Gossamer Bio·NASDAQ
--
--(--)
--
--(--)
GOSS fundamentals
Gossamer Bio (GOSS) released its earnings on Aug 5, 2025: revenue was 11.49M (YoY -88.01%), beat estimates; EPS was -0.17 (YoY -177.27%), beat estimates.
Revenue / YoY
11.49M
-88.01%
EPS / YoY
-0.17
-177.27%
Report date
Aug 5, 2025
EPS
Actual | -0.87 | -1 | -0.8 | -0.88 | -0.78 | -0.8 | -0.8 | -0.74 | -0.76 | -0.74 | -0.65 | -0.59 | -0.52 | -0.45 | -0.21 | -0.21 | -0.19 | 0.22 | -0.14 | -0.15 | -0.16 | -0.17 | ||||
Forecast | -0.7867 | -0.8633 | -0.8533 | -0.79 | -0.756 | -0.758 | -0.785 | -0.7513 | -0.7661 | -0.691 | -0.6428 | -0.623 | -0.53 | -0.4892 | -0.2565 | -0.2083 | -0.1901 | 0.5067 | -0.1472 | -0.17 | -0.1871 | -0.1771 | ||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -10.59% | -15.83% | +6.25% | -11.39% | -3.17% | -5.54% | -1.91% | +1.50% | +0.80% | -7.09% | -1.12% | +5.30% | +1.89% | +8.01% | +18.13% | -0.82% | +0.05% | -56.58% | +4.89% | +11.76% | +14.48% | +4.01% |
Revenue
Actual | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95.84M | 9.48M | 9.38M | 9.89M | 11.49M |
Forecast | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114.29M | 8.53M | 6.83M | 4.07M | 5.41M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -16.14% | +11.14% | +37.24% | +143.13% | +112.41% |
Earnings Call
You can ask Aime
What is Gossamer Bio's gross profit margin?What does Gossamer Bio do and what are its main business segments?What were the key takeaways from Gossamer Bio's earnings call?What is the revenue and EPS growth rate for Gossamer Bio year over year?What is the market's earnings forecast for Gossamer Bio next quarter?What is Gossamer Bio's latest dividend and current dividend yield?What guidance did Gossamer Bio's management provide for the next earnings period?What were the key takeaways from Gossamer Bio’s earnings call?
